2024-04-012025-03-312025-03-31false12021314R HETTIGE MEDICAL PRACTICE LTD2025-07-09falseiso4217:GBPxbrli:pure120213142024-03-31120213142025-03-31120213142024-04-012025-03-31120213142023-03-31120213142024-03-31120213142023-04-012024-03-3112021314bus:SmallEntities2024-04-012025-03-3112021314bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3112021314bus:FullAccounts2024-04-012025-03-3112021314bus:PrivateLimitedCompanyLtd2024-04-012025-03-3112021314core:WithinOneYear2025-03-3112021314core:AfterOneYear2025-03-3112021314core:WithinOneYear2024-03-3112021314core:AfterOneYear2024-03-3112021314core:ShareCapital2025-03-3112021314core:SharePremium2025-03-3112021314core:RevaluationReserve2025-03-3112021314core:OtherReservesSubtotal2025-03-3112021314core:RetainedEarningsAccumulatedLosses2025-03-3112021314core:ShareCapital2024-03-3112021314core:SharePremium2024-03-3112021314core:RevaluationReserve2024-03-3112021314core:OtherReservesSubtotal2024-03-3112021314core:RetainedEarningsAccumulatedLosses2024-03-3112021314core:LandBuildings2025-03-3112021314core:PlantMachinery2025-03-3112021314core:Vehicles2025-03-3112021314core:FurnitureFittings2025-03-3112021314core:OfficeEquipment2025-03-3112021314core:NetGoodwill2025-03-3112021314core:IntangibleAssetsOtherThanGoodwill2025-03-3112021314core:ListedExchangeTraded2025-03-3112021314core:UnlistedNon-exchangeTraded2025-03-3112021314core:LandBuildings2024-03-3112021314core:PlantMachinery2024-03-3112021314core:Vehicles2024-03-3112021314core:FurnitureFittings2024-03-3112021314core:OfficeEquipment2024-03-3112021314core:NetGoodwill2024-03-3112021314core:IntangibleAssetsOtherThanGoodwill2024-03-3112021314core:ListedExchangeTraded2024-03-3112021314core:UnlistedNon-exchangeTraded2024-03-3112021314core:LandBuildings2024-04-012025-03-3112021314core:PlantMachinery2024-04-012025-03-3112021314core:Vehicles2024-04-012025-03-3112021314core:FurnitureFittings2024-04-012025-03-3112021314core:OfficeEquipment2024-04-012025-03-3112021314core:NetGoodwill2024-04-012025-03-3112021314core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3112021314core:ListedExchangeTraded2024-04-012025-03-3112021314core:UnlistedNon-exchangeTraded2024-04-012025-03-3112021314core:MoreThanFiveYears2024-04-012025-03-3112021314core:Non-currentFinancialInstruments2025-03-3112021314core:Non-currentFinancialInstruments2024-03-3112021314dpl:CostSales2024-04-012025-03-3112021314dpl:DistributionCosts2024-04-012025-03-3112021314core:LandBuildings2024-04-012025-03-3112021314core:PlantMachinery2024-04-012025-03-3112021314core:Vehicles2024-04-012025-03-3112021314core:FurnitureFittings2024-04-012025-03-3112021314core:OfficeEquipment2024-04-012025-03-3112021314dpl:AdministrativeExpenses2024-04-012025-03-3112021314core:NetGoodwill2024-04-012025-03-3112021314core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3112021314dpl:GroupUndertakings2024-04-012025-03-3112021314dpl:ParticipatingInterests2024-04-012025-03-3112021314dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3112021314core:ListedExchangeTraded2024-04-012025-03-3112021314dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3112021314core:UnlistedNon-exchangeTraded2024-04-012025-03-3112021314dpl:CostSales2023-04-012024-03-3112021314dpl:DistributionCosts2023-04-012024-03-3112021314core:LandBuildings2023-04-012024-03-3112021314core:PlantMachinery2023-04-012024-03-3112021314core:Vehicles2023-04-012024-03-3112021314core:FurnitureFittings2023-04-012024-03-3112021314core:OfficeEquipment2023-04-012024-03-3112021314dpl:AdministrativeExpenses2023-04-012024-03-3112021314core:NetGoodwill2023-04-012024-03-3112021314core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3112021314dpl:GroupUndertakings2023-04-012024-03-3112021314dpl:ParticipatingInterests2023-04-012024-03-3112021314dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3112021314core:ListedExchangeTraded2023-04-012024-03-3112021314dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3112021314core:UnlistedNon-exchangeTraded2023-04-012024-03-3112021314core:NetGoodwill2025-03-3112021314core:IntangibleAssetsOtherThanGoodwill2025-03-3112021314core:LandBuildings2025-03-3112021314core:PlantMachinery2025-03-3112021314core:Vehicles2025-03-3112021314core:FurnitureFittings2025-03-3112021314core:OfficeEquipment2025-03-3112021314core:AfterOneYear2025-03-3112021314core:WithinOneYear2025-03-3112021314core:ListedExchangeTraded2025-03-3112021314core:UnlistedNon-exchangeTraded2025-03-3112021314core:ShareCapital2025-03-3112021314core:SharePremium2025-03-3112021314core:RevaluationReserve2025-03-3112021314core:OtherReservesSubtotal2025-03-3112021314core:RetainedEarningsAccumulatedLosses2025-03-3112021314core:NetGoodwill2024-03-3112021314core:IntangibleAssetsOtherThanGoodwill2024-03-3112021314core:LandBuildings2024-03-3112021314core:PlantMachinery2024-03-3112021314core:Vehicles2024-03-3112021314core:FurnitureFittings2024-03-3112021314core:OfficeEquipment2024-03-3112021314core:AfterOneYear2024-03-3112021314core:WithinOneYear2024-03-3112021314core:ListedExchangeTraded2024-03-3112021314core:UnlistedNon-exchangeTraded2024-03-3112021314core:ShareCapital2024-03-3112021314core:SharePremium2024-03-3112021314core:RevaluationReserve2024-03-3112021314core:OtherReservesSubtotal2024-03-3112021314core:RetainedEarningsAccumulatedLosses2024-03-3112021314core:NetGoodwill2023-03-3112021314core:IntangibleAssetsOtherThanGoodwill2023-03-3112021314core:LandBuildings2023-03-3112021314core:PlantMachinery2023-03-3112021314core:Vehicles2023-03-3112021314core:FurnitureFittings2023-03-3112021314core:OfficeEquipment2023-03-3112021314core:AfterOneYear2023-03-3112021314core:WithinOneYear2023-03-3112021314core:ListedExchangeTraded2023-03-3112021314core:UnlistedNon-exchangeTraded2023-03-3112021314core:ShareCapital2023-03-3112021314core:SharePremium2023-03-3112021314core:RevaluationReserve2023-03-3112021314core:OtherReservesSubtotal2023-03-3112021314core:RetainedEarningsAccumulatedLosses2023-03-3112021314core:AfterOneYear2024-04-012025-03-3112021314core:WithinOneYear2024-04-012025-03-3112021314core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3112021314core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3112021314core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3112021314core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3112021314core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3112021314core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3112021314core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3112021314core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3112021314core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3112021314core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3112021314core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3112021314core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3112021314core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3112021314core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3112021314core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3112021314core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3112021314core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3112021314core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3112021314core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3112021314core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3112021314core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3112021314core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3112021314core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3112021314core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3112021314core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3112021314core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3112021314core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3112021314bus:Director12024-04-012025-03-3112021314bus:Director22024-04-012025-03-31

R HETTIGE MEDICAL PRACTICE LTD

Registered Number
12021314
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

R HETTIGE MEDICAL PRACTICE LTD
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

HETTIGE, Roland
HETTIGE, Susannah Catherine

Registered Address

1st Floor, Buckley House 31a The Hundred
Romsey
SO51 8GD

Registered Number

12021314 (England and Wales)
R HETTIGE MEDICAL PRACTICE LTD
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets3107,6372,895
107,6372,895
Current assets
Debtors421,51225,495
Cash at bank and on hand137,741234,904
159,253260,399
Creditors amounts falling due within one year6(8,334)(44,179)
Net current assets (liabilities)150,919216,220
Total assets less current liabilities258,556219,115
Net assets258,556219,115
Capital and reserves
Called up share capital150150
Profit and loss account258,406218,965
Shareholders' funds258,556219,115
The financial statements were approved and authorised for issue by the Board of Directors on 9 July 2025, and are signed on its behalf by:
HETTIGE, Roland
Director
Registered Company No. 12021314
R HETTIGE MEDICAL PRACTICE LTD
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Fixtures and fittings25
Vehicles25
Office Equipment50
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
2.Average number of employees

20252024
Average number of employees during the year44
3.Tangible fixed assets

Vehicles

Office Equipment

Total

£££
Cost or valuation
At 01 April 24-14,69414,694
Additions122,124-122,124
At 31 March 25122,12414,694136,818
Depreciation and impairment
At 01 April 24-11,79911,799
Charge for year16,1441,23817,382
At 31 March 2516,14413,03729,181
Net book value
At 31 March 25105,9801,657107,637
At 31 March 24-2,8952,895
4.Debtors: amounts due after one year
5.Current asset investments
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables70105
Taxation and social security5,15733,797
Other creditors4678,146
Accrued liabilities and deferred income2,6402,131
Total8,33444,179